X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (191) 191
index medicus (132) 132
male (122) 122
female (121) 121
middle aged (113) 113
oncology (113) 113
aged (89) 89
adult (87) 87
hematology (87) 87
prognosis (82) 82
non-hodgkins-lymphoma (67) 67
antineoplastic combined chemotherapy protocols - therapeutic use (61) 61
chemotherapy (60) 60
treatment outcome (54) 54
lymphomas (51) 51
aged, 80 and over (48) 48
lymphoma, large b-cell, diffuse - drug therapy (46) 46
rituximab (46) 46
b-cell lymphoma (45) 45
hematology, oncology and palliative medicine (40) 40
cancer (39) 39
hemic and lymphatic diseases (33) 33
lymphoma (33) 33
neoplasm staging (32) 32
disease-free survival (31) 31
lymphoma, large b-cell, diffuse - pathology (30) 30
radiotherapy (27) 27
combined modality therapy (26) 26
adolescent (25) 25
diffuse large b-cell lymphoma (25) 25
immune system diseases (25) 25
lymphoma, large b-cell, diffuse - mortality (25) 25
survival (25) 25
lymphoma, b-cell, marginal zone - drug therapy (24) 24
lymphoma, large b-cell, diffuse - genetics (23) 23
lymphoma, b-cell, marginal zone - pathology (22) 22
abridged index medicus (21) 21
primary cns lymphoma (21) 21
risk factors (21) 21
survival analysis (21) 21
transplantation (21) 21
immunohistochemistry (20) 20
young adult (20) 20
high-dose methotrexate (19) 19
non-hodgkin's lymphomas (19) 19
retrospective studies (19) 19
anti-bacterial agents - therapeutic use (18) 18
antineoplastic combined chemotherapy protocols - administration & dosage (18) 18
care and treatment (18) 18
central nervous system neoplasms - therapy (18) 18
lymphoma - therapy (18) 18
lymphoma, b-cell, marginal zone - microbiology (18) 18
gene expression profiling (17) 17
follow-up studies (16) 16
health aspects (16) 16
lymphoma, large b-cell, diffuse - metabolism (16) 16
methotrexate (16) 16
phase-ii (16) 16
antineoplastic agents - therapeutic use (15) 15
central-nervous-system (15) 15
cyclophosphamide - therapeutic use (15) 15
doxorubicin - therapeutic use (15) 15
high-dose chemotherapy (15) 15
lymphoma - drug therapy (15) 15
prednisone - therapeutic use (15) 15
survival rate (15) 15
therapy (15) 15
vincristine - therapeutic use (15) 15
central nervous system neoplasms - drug therapy (14) 14
expression (14) 14
kaplan-meier estimate (14) 14
malt lymphoma (14) 14
stem-cell transplantation (14) 14
vincristine - administration & dosage (14) 14
cyclophosphamide - administration & dosage (13) 13
dlbcl (13) 13
doxorubicin - administration & dosage (13) 13
prednisone - administration & dosage (13) 13
radiation-therapy (13) 13
recurrence (13) 13
tissue lymphoma (13) 13
antibodies, monoclonal, murine-derived - administration & dosage (12) 12
central nervous system (12) 12
central nervous system neoplasms - pathology (12) 12
lymphoma - radiotherapy (12) 12
pathology (12) 12
stem cell transplantation (12) 12
analysis (11) 11
antibodies, monoclonal, murine-derived - therapeutic use (11) 11
chlamydia-psittaci (11) 11
gene-expression (11) 11
helicobacter pylori (11) 11
intraocular lymphoma (11) 11
lymphoma - pathology (11) 11
lymphoma, non-hodgkin - therapy (11) 11
malignant-lymphoma (11) 11
methotrexate - administration & dosage (11) 11
tumor suppressor protein p53 - genetics (11) 11
tumors (11) 11
antineoplastic combined chemotherapy protocols - adverse effects (10) 10
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15, pp. 1830 - 1831
Journal Article
The Oncologist, ISSN 1083-7159, 12/2014, Volume 19, Issue 12, pp. 1289 - 1290
The authors thank Hoppe et al. for their interest in the study of patients with limited-stage diffuse large B-cell lymphoma of the bone (PB-DLBCL). There is... 
Letters to the Editor
Journal Article
The Oncologist, ISSN 1083-7159, 12/2014, Volume 19, Issue 12, pp. 1289 - 1290
The authors thank Hoppe et al. for their interest in the study of patients with limited‐stage diffuse large B‐cell lymphoma of the bone (PB‐DLBCL). There is... 
Journal Article
JAMA Ophthalmology, ISSN 2168-6165, 06/2015, Volume 133, Issue 6, pp. 726 - 727
Journal Article
American Journal of Pathology, The, ISSN 0002-9440, 2017
AKT signaling is important for proliferation and survival of tumor cells. The clinical significance of AKT activation in diffuse large B-cell lymphoma (DLBCL)... 
Pathology
Journal Article
Ophthalmology, ISSN 0161-6420, 08/2011, Volume 118, Issue 8, pp. 1692 - 1692.e1
Journal Article
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting, 01/2019, Volume 39, pp. 454 - 466
Journal Article
Ophthalmology, ISSN 0161-6420, 2011, Volume 118, Issue 8, pp. 1692 - e1
Journal Article
Ophthalmology, ISSN 0161-6420, 2011, Volume 118, Issue 8, pp. 1692 - 1692.e1
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2013, Volume 31, Issue 27, pp. 3444 - 3445
Journal Article